Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Precision Medicine Randomized Trial for Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemian Based on a Functional Approach

NCT07522801 is registered in ClinicalTrials.gov with Philippe ROUSSELOT as lead sponsor.

NCT NCT07522801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07522801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Precision Medicine Randomized Trial for Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemian Based on a Functional Approach
Lead sponsor
Philippe ROUSSELOT
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
March 1, 2030
Enrollment
93 (estimated)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

lal